Posted by notfred on April 16, 2007, at 0:18:46
In reply to Re: Stablon (tianeptine)?, posted by naughtypuppy on April 15, 2007, at 8:59:05
> It's not just the pharma companies. My pdoc applied to the government to get tianapine imported was refused.
Stablon has not been tested at all in the US, Foreign studies are not accepted by the FDA, to approve a new med. While this seems a PITA, there were no flipper babies in the US, due to the FDA's strict requirements.
The rounds of testing are very expensive. Even if a patentable analogue was tested and approved, as
Stablon is now off patent generic tianeptine could then be offered, using the existing studies on the analogue. So the pharma that pays for the testing
does not stand to get any ROI. This is the way a business operates.As I said, the reasons are often complex.
I think the gov needs to step in and do the testing on tianeptine, then we would have generics, as there would be ROI in offering them.
poster:notfred
thread:749517
URL: http://www.dr-bob.org/babble/20070413/msgs/750180.html